Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    Neuralstem
Show Display Options
Rank Status Study
1 Recruiting A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: NSI-189
2 Recruiting Study of NSI-189 for Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: 80 Milligrams NSI-189;   Drug: Placebo;   Drug: 40 Milligrams NSI-189
3 Completed Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects
Condition: Depression
Interventions: Drug: NSI-189 Phosphate;   Drug: microcrystalline cellulose capsules
4 Completed Single-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189
Condition: Depression
Intervention: Drug: NSI-189 Phosphate
5 Active, not recruiting Safety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCI
Condition: Spinal Cord Injury (SCI)
Intervention: Device: Human spinal cord stem cells.
6 Active, not recruiting Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Device: Human spinal cord stem cell implantation
7 Active, not recruiting Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Device: surgical implantation

Indicates status has not been verified in more than two years